Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report

There are few reports of rhabdomyolysis caused by anticoagulants, and it is extremely rare for it to be caused by dabigatran etexilate. An 86-year-old female experienced sudden muscle weakness and pain, a significant increase in Creatine kinase, and renal impairment after oral administration of dabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Tingting, Liu, Lulu, Liu, Jiayi, Zhang, Zhengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186465/
https://www.ncbi.nlm.nih.gov/pubmed/35642709
_version_ 1784724940167053312
author Zheng, Tingting
Liu, Lulu
Liu, Jiayi
Zhang, Zhengxiang
author_facet Zheng, Tingting
Liu, Lulu
Liu, Jiayi
Zhang, Zhengxiang
author_sort Zheng, Tingting
collection PubMed
description There are few reports of rhabdomyolysis caused by anticoagulants, and it is extremely rare for it to be caused by dabigatran etexilate. An 86-year-old female experienced sudden muscle weakness and pain, a significant increase in Creatine kinase, and renal impairment after oral administration of dabigatran etexilate for 3 weeks. The enhanced thigh MRI showed abnormal signal in multiple thigh muscle groups, indicating that the lesions should be considered inflammatory diseases. In conclusion, the possibility of rhabdomyolysis should be ruled out when muscle weakness and myalgia occur at the beginning of dabigatran etexilate treatment.
format Online
Article
Text
id pubmed-9186465
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Musculoskeletal and Neuronal Interactions
record_format MEDLINE/PubMed
spelling pubmed-91864652022-07-05 Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report Zheng, Tingting Liu, Lulu Liu, Jiayi Zhang, Zhengxiang J Musculoskelet Neuronal Interact Case Report There are few reports of rhabdomyolysis caused by anticoagulants, and it is extremely rare for it to be caused by dabigatran etexilate. An 86-year-old female experienced sudden muscle weakness and pain, a significant increase in Creatine kinase, and renal impairment after oral administration of dabigatran etexilate for 3 weeks. The enhanced thigh MRI showed abnormal signal in multiple thigh muscle groups, indicating that the lesions should be considered inflammatory diseases. In conclusion, the possibility of rhabdomyolysis should be ruled out when muscle weakness and myalgia occur at the beginning of dabigatran etexilate treatment. International Society of Musculoskeletal and Neuronal Interactions 2022 /pmc/articles/PMC9186465/ /pubmed/35642709 Text en Copyright: © Journal of Musculoskeletal and Neuronal Interactions https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Zheng, Tingting
Liu, Lulu
Liu, Jiayi
Zhang, Zhengxiang
Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title_full Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title_fullStr Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title_full_unstemmed Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title_short Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report
title_sort rhabdomyolysis happened after the start of dabigatran etexilate treatment: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186465/
https://www.ncbi.nlm.nih.gov/pubmed/35642709
work_keys_str_mv AT zhengtingting rhabdomyolysishappenedafterthestartofdabigatranetexilatetreatmentacasereport
AT liululu rhabdomyolysishappenedafterthestartofdabigatranetexilatetreatmentacasereport
AT liujiayi rhabdomyolysishappenedafterthestartofdabigatranetexilatetreatmentacasereport
AT zhangzhengxiang rhabdomyolysishappenedafterthestartofdabigatranetexilatetreatmentacasereport

Ejemplares similares